Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

Tenley C Archer1,2, Elizabeth L Mahoney1, Scott L Pomeroy3,4

  • 1Department of Neurology, Boston Children's Hospital, Boston, MA, 02115, USA.

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|April 8, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Not Just Half a Doctor: Promoting Humanism During Stressful Times.

Annals of the Child Neurology Society·2026
Same author

The Role of Academic Medical Centers in Personalized Experimental Therapeutic Development: Key Considerations.

Neurology·2026
Same author

Interferon Restores Antigen Presentation and Sensitizes Medulloblastoma to T Cell Killing.

bioRxiv : the preprint server for biology·2025
Same author

An Approach to Successful Development of Clinician-Scientists in Neurology: The NINDS R25 Experience.

Annals of neurology·2024
Same author

WNT signalling control by KDM5C during development affects cognition.

Nature·2024
Same author

Developmental basis of SHH medulloblastoma heterogeneity.

Nature communications·2024

Cancer genomics identified four medulloblastoma subgroups with distinct molecular features. This molecular classification improves prognosis prediction and guides personalized treatment strategies, including targeted therapies.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Medulloblastomas are aggressive pediatric brain tumors.
  • Cancer genomics has advanced the understanding of tumor heterogeneity.

Purpose of the Study:

  • To present the molecular classification of medulloblastomas.
  • To highlight the clinical implications of this classification.

Main Methods:

  • Analysis of transcription profiles.
  • Identification of DNA alterations.

Main Results:

  • Discovery of four distinct medulloblastoma subgroups.
  • Each subgroup exhibits unique molecular characteristics.
  • Correlation between molecular subgroup and clinical outcome.
Keywords:
DNA methylationGenomicGroup 3Group 4MYCMedulloblastomaSHHSubgroupsWHOWNT

Related Experiment Videos

Conclusions:

  • Molecular classification refines medulloblastoma prognostication.
  • Enables tailored treatment intensity (chemotherapy, radiation).
  • Facilitates the development of targeted therapies for medulloblastoma.